DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/4drs65/u_s_market_for_ga) has announced the addition of the "U.S. Market for Gastro Intestinal Devices (Executive Summary)" report to their offering.
In 2011, the U.S. market for gastrointestinal endoscopic devices was valued at nearly $1.7 billion. The GI endoscopic market includes:
- GI endoscopes,
- Capsule endoscopy,
- Virtual colonoscopy,
- Stenting and dilation devices,
- ERCP devices,
- Biopsy forceps,
- Polypectomy snares,
- FNA devices,
- Specimen and foreign body removal devices,
- Hemostasis devices,
- Anti-reflux devices, and
- Enteral feeding devices
High demand for GI screening and intervention procedures resulted in the market experiencing a high growth rate prior to the recession. Over the forecast period, market expansion will be driven by procedural growth and higher GI disease incidences. This will result in growth returning to pre-recession levels by 2018.
Within the gastrointestinal endoscopic device market, companies such as Boston Scientific, Cook Medical, Given Imaging, Olympus and Pentax lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
For more information visit http://www.researchandmarkets.com/research/4drs65/u_s_market_for_ga